ATE445160T1 - Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon - Google Patents
Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davonInfo
- Publication number
- ATE445160T1 ATE445160T1 AT02757275T AT02757275T ATE445160T1 AT E445160 T1 ATE445160 T1 AT E445160T1 AT 02757275 T AT02757275 T AT 02757275T AT 02757275 T AT02757275 T AT 02757275T AT E445160 T1 ATE445160 T1 AT E445160T1
- Authority
- AT
- Austria
- Prior art keywords
- stroke
- markers
- methods
- diagnosis
- patient
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000030886 Traumatic Brain injury Diseases 0.000 title 1
- 208000006011 Stroke Diseases 0.000 abstract 5
- 238000003745 diagnosis Methods 0.000 abstract 3
- 208000022306 Cerebral injury Diseases 0.000 abstract 2
- 208000032109 Transient ischaemic attack Diseases 0.000 abstract 2
- 238000011156 evaluation Methods 0.000 abstract 2
- 201000010875 transient cerebral ischemia Diseases 0.000 abstract 2
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 208000001286 intracranial vasospasm Diseases 0.000 abstract 1
- 239000013610 patient sample Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31377501P | 2001-08-20 | 2001-08-20 | |
| US33496401P | 2001-11-30 | 2001-11-30 | |
| US34648502P | 2002-01-02 | 2002-01-02 | |
| PCT/US2002/026604 WO2003016910A1 (en) | 2001-08-20 | 2002-08-20 | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE445160T1 true ATE445160T1 (de) | 2009-10-15 |
Family
ID=27405676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02757275T ATE445160T1 (de) | 2001-08-20 | 2002-08-20 | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7427490B2 (de) |
| EP (1) | EP1419388B1 (de) |
| JP (1) | JP2005522669A (de) |
| AT (1) | ATE445160T1 (de) |
| CA (1) | CA2457775A1 (de) |
| DE (1) | DE60233949D1 (de) |
| WO (1) | WO2003016910A1 (de) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6991907B1 (en) * | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
| US6627404B1 (en) * | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
| CA2263063C (en) * | 1999-02-26 | 2004-08-10 | Skye Pharmatech Incorporated | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| US6780606B1 (en) * | 1999-02-26 | 2004-08-24 | Synx Pharma, Inc. | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| US7927784B2 (en) | 2000-12-20 | 2011-04-19 | Ev3 | Vascular lumen debulking catheters and methods |
| US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US20040176914A1 (en) * | 2001-04-13 | 2004-09-09 | Biosite Incorporated | Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential |
| US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| US20030199000A1 (en) * | 2001-08-20 | 2003-10-23 | Valkirs Gunars E. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7524635B2 (en) * | 2003-04-17 | 2009-04-28 | Biosite Incorporated | Methods and compositions for measuring natriuretic peptides and uses thereof |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| US20040219509A1 (en) * | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20040209307A1 (en) * | 2001-08-20 | 2004-10-21 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7608406B2 (en) * | 2001-08-20 | 2009-10-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20030040660A1 (en) * | 2001-08-27 | 2003-02-27 | George Jackowski | Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein |
| JP2006526140A (ja) * | 2002-12-24 | 2006-11-16 | バイオサイト インコーポレイテッド | 鑑別診断のためのマーカーおよびその使用方法 |
| WO2005037286A1 (en) * | 2003-03-25 | 2005-04-28 | Vasopharm Biotech Gmbh | Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia |
| US7341838B2 (en) * | 2003-04-17 | 2008-03-11 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US20070037208A1 (en) * | 2003-05-29 | 2007-02-15 | Foote Robert S | Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| GB2404981A (en) * | 2003-08-15 | 2005-02-16 | Univ Geneve | Diagnostic method for stroke |
| DK2341350T3 (en) * | 2003-09-20 | 2018-02-05 | Electrophoretics Ltd | DIAGNOSTIC PROCEDURE FOR BRAKE INJURY-RELATED DISORDERS BASED ON DJ-1 DETECTION |
| EP1519194A1 (de) * | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | Die Verwendung von GFAP zur Identifizierung einer Intrazerebralblutung |
| US20050164238A1 (en) * | 2003-09-29 | 2005-07-28 | Biosite, Inc. | Methods and compositions for the diagnosis of sepsis |
| CN1316037C (zh) * | 2003-12-19 | 2007-05-16 | 叶尚勉 | 检测待测标本中生存素表达量的诊断试剂、检测方法及应用 |
| EP1562046A1 (de) * | 2004-02-03 | 2005-08-10 | B.R.A.H.M.S Aktiengesellschaft | Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben |
| US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| US7300494B2 (en) * | 2005-02-24 | 2007-11-27 | Hamilton Sundstrand Corporation | On-board inert gas generation system with compressor surge protection |
| US7794413B2 (en) | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
| US20070099239A1 (en) * | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| US20070038173A1 (en) * | 2005-07-27 | 2007-02-15 | Fox Hollow Technologies, Inc. | Methods affecting markers in patients having vascular disease |
| WO2007028070A2 (en) * | 2005-08-30 | 2007-03-08 | Biosite, Inc. | Use of soluble flt-1 and its fragments in cardiovascular conditions |
| US7807378B2 (en) * | 2005-12-29 | 2010-10-05 | Industrial Technology Research Institute (Itri) | Method of diagnosing myasthenia gravis and kits therefor |
| US7989207B2 (en) | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
| WO2007103568A2 (en) * | 2006-03-09 | 2007-09-13 | Biosite, Inc. | Methods and compositions for the diagnosis of diseases of the aorta |
| US20080118924A1 (en) * | 2006-05-26 | 2008-05-22 | Buechler Kenneth F | Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
| US20100086481A1 (en) * | 2006-07-11 | 2010-04-08 | Baird Alison E | Differential expression of molecules associated with intra-cerebral hemorrhage |
| WO2008060607A2 (en) | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for monitoring and risk prediction in cardiorenal syndrome |
| EP2095106B1 (de) * | 2006-11-14 | 2013-03-20 | Alere San Diego, Inc. | Verfahren und zusammensetzungen zur diagnose und prognose von nierenarterienstenose |
| SE532103C2 (sv) | 2006-12-12 | 2009-10-27 | Knut Johansen | Metod för att bestämma hälsostatus från analyter i vätskeprover |
| US8221995B2 (en) | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| CA2685382C (en) | 2007-05-01 | 2023-02-21 | The Regents Of The University Of California | Methods for diagnosing ischemia |
| JP5339227B2 (ja) | 2007-05-18 | 2013-11-13 | 国立大学法人 千葉大学 | アクロレイン、インターロイキン−６及びｃｒｐの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法 |
| KR100956764B1 (ko) * | 2007-11-27 | 2010-05-12 | 한국 한의학 연구원 | 헤모글로빈-알파 서브유닛을 바이오 마커로 이용한 뇌졸중진단방법 |
| WO2009075863A2 (en) * | 2007-12-11 | 2009-06-18 | New York University School Of Medicine | Method for diagnosing stroke |
| WO2009091581A2 (en) * | 2008-01-18 | 2009-07-23 | Vatrix Medical, Inc. | Diagnostic biomarkers for vascular aneurysm |
| KR101110758B1 (ko) | 2008-06-02 | 2012-02-15 | 경북대학교 산학협력단 | 뇌졸중 표적용 펩티드 및 이의 용도 |
| CN102203129B (zh) * | 2008-08-01 | 2014-12-31 | 比奥-拉德创新公司 | 用于体外诊断中风的方法 |
| US12601749B2 (en) | 2008-08-11 | 2026-04-14 | Banyan Biomarkers, Inc. | Biomarker detection process and assay of neurological condition |
| JP5781436B2 (ja) * | 2008-08-11 | 2015-09-24 | バンヤン・バイオマーカーズ・インコーポレーテッド | 神経学的状態のバイオマーカー検出方法およびアッセイ |
| WO2010017972A1 (en) * | 2008-08-13 | 2010-02-18 | Roche Diagnostics Gmbh | D-dimer, troponin, nt-probnp for pulmonary embolism |
| CN102257386B (zh) * | 2008-10-24 | 2014-12-31 | B.R.A.H.M.S有限公司 | 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估 |
| CA2751090A1 (en) * | 2009-01-30 | 2010-08-05 | Electrophoretics Limited | Method for the in vitro diagnosis of stroke |
| WO2010096331A1 (en) | 2009-02-11 | 2010-08-26 | Duke University | Sensors incorporating antibodies and methods of making and using the same |
| CN101825627B (zh) * | 2009-03-02 | 2013-10-02 | 江苏迈迪基因生物科技有限公司 | 心力衰竭的生物标志物的联合并行检测方法及诊断试剂盒 |
| JP5747370B2 (ja) | 2009-03-31 | 2015-07-15 | 国立大学法人浜松医科大学 | 高病原性口腔細菌の高感度検出法 |
| HRP20191862T1 (hr) * | 2009-04-14 | 2019-12-27 | B.R.A.H.M.S Gmbh | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina |
| US20100312139A1 (en) * | 2009-06-04 | 2010-12-09 | Board Of Regents Of The University Of Texas System | Method for Identifying Mammals at Risk for Elevated intracranial Pressure |
| AU2010262952B2 (en) * | 2009-06-19 | 2016-01-07 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| CA2807645C (en) * | 2009-08-07 | 2021-09-07 | Affinimark Technologies, Inc. | Device and methods for the immunological identification of cerebrospinal fluid |
| AU2010291933B2 (en) | 2009-09-14 | 2016-09-08 | Banyan Biomarkers, Inc. | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury |
| CA2780301A1 (en) | 2009-11-13 | 2011-05-19 | Bg Medicine, Inc. | Risk factors and prediction of myocardial infarction |
| EP2504466B1 (de) | 2009-11-23 | 2019-11-20 | Proxim Diagnostics Corporation | Gesteuerte elektrochemische aktivierung von elektroden auf kohlenstoffbasis |
| JP2011206049A (ja) * | 2010-03-08 | 2011-10-20 | Sumio Sugano | 壊死マーカー及びその用途 |
| WO2011143412A1 (en) * | 2010-05-14 | 2011-11-17 | University Of Connecticut | Methods for the detection and monitoring of acute myocardial infarction |
| WO2011160096A2 (en) * | 2010-06-17 | 2011-12-22 | Banyan Biomarkers, Inc. | Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition |
| CA2804763C (en) | 2010-07-14 | 2023-01-03 | The Regents Of The University Of California | Biomarkers for diagnosis of transient ischemic attacks |
| WO2012009567A2 (en) | 2010-07-15 | 2012-01-19 | The Regents Of The University Of California | Biomarkers for diagnosis of stroke and its causes |
| WO2012051519A2 (en) * | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
| WO2012121978A2 (en) | 2011-03-04 | 2012-09-13 | The Regents Of The University Of California | Biomarkers for the diagnosis of lacunar stroke |
| US20140141458A1 (en) | 2011-05-12 | 2014-05-22 | The Johns Hopkins University | Assay reagents for a neurogranin diagnostic kit |
| WO2013015822A1 (en) | 2011-07-25 | 2013-01-31 | Mikhail Briman | Cartridge for diagnostic testing |
| US20140322722A1 (en) * | 2011-09-30 | 2014-10-30 | The Research Institute At Nationwide Children's Hospital | Compositions and methods for detection of defensins in a patient sample |
| CN103998938B (zh) | 2011-10-17 | 2016-06-15 | 霍夫曼-拉罗奇有限公司 | 风险患者和中风原因的基于肌钙蛋白和bnp的诊断 |
| EP3290924B1 (de) * | 2011-12-01 | 2021-10-13 | Roche Diagnostics GmbH | Nt-pro-anp und nt-pro-bnp zur diagnose eines schlaganfalls |
| GB2497138A (en) * | 2011-12-02 | 2013-06-05 | Randox Lab Ltd | Biomarkers for stroke and stroke subtype diagnosis. |
| CN103163295B (zh) * | 2011-12-08 | 2015-11-18 | 吴宗贵 | 一种用于急性冠脉综合征的液相芯片试剂盒以其制备方法 |
| WO2013103781A1 (en) | 2012-01-07 | 2013-07-11 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
| JP2015507205A (ja) * | 2012-02-12 | 2015-03-05 | ビージー メディシン，インコーポレイテッド | 有害事象のリスク因子および予測 |
| CN103308673B (zh) * | 2012-03-08 | 2017-05-31 | 思芬构技术有限公司 | 用于预测雌性对象中发生心血管事件的风险的方法 |
| HK1206425A1 (en) | 2012-03-13 | 2016-01-08 | The Johns Hopkins University | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
| WO2014110674A1 (en) * | 2013-01-15 | 2014-07-24 | University Of Manitoba | Biomarkers for rapid detection of an occurrence of a stroke event |
| GB201309928D0 (en) * | 2013-06-04 | 2013-07-17 | Randox Lab Ltd | Method |
| US10534003B2 (en) | 2013-07-17 | 2020-01-14 | The Johns Hopkins University | Multi-protein biomarker assay for brain injury detection and outcome |
| WO2015019976A1 (ja) * | 2013-08-05 | 2015-02-12 | 第一三共株式会社 | 肝障害のタイプの検査方法 |
| WO2015187227A2 (en) | 2014-03-13 | 2015-12-10 | Duke University | Electronic platform for sensing and control of electrochemical reactions |
| EP3029466A1 (de) * | 2014-12-03 | 2016-06-08 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Verfahren zur Unterscheidung eines ischämischen Schlaganfalls von einem hämorrhagischem Schlaganfall |
| US11078298B2 (en) | 2016-10-28 | 2021-08-03 | Banyan Biomarkers, Inc. | Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods |
| GB201619823D0 (en) | 2016-11-23 | 2017-01-04 | Randox Laboratories Ltd And Teoranta Randox | GFAP accumulating stroke |
| JP7269182B2 (ja) * | 2017-05-30 | 2023-05-08 | アボット・ラボラトリーズ | 心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法 |
| EP3655545B1 (de) | 2017-07-18 | 2023-10-18 | The Research Foundation for The State University of New York | Biomarker für intrakranielles aneurysma |
| CN107368708B (zh) * | 2017-08-14 | 2018-03-16 | 东莞博奥木华基因科技有限公司 | 一种精准分析dmd基因结构变异断点的方法及系统 |
| WO2019099732A1 (en) * | 2017-11-16 | 2019-05-23 | Brainbox Solutions, Inc. | Protein biomarker indicators of neurological injury and/or disease and methods of use thereof |
| CN111480081A (zh) * | 2017-12-13 | 2020-07-31 | 豪夫迈·罗氏有限公司 | 用于预测脑卒中的循环血管生成素-2(Ang-2)和胰岛素样生长因子结合蛋白7(IGFBP7) |
| WO2020053881A1 (en) * | 2018-09-10 | 2020-03-19 | Indian Institute Of Technology Bombay | A device to detect stroke |
| US20210187053A1 (en) * | 2019-12-23 | 2021-06-24 | Hemopet | Compound for treating oxidative stress in mammals |
| US11181538B2 (en) | 2019-12-23 | 2021-11-23 | Hemopet | Oxidative stress biomarkers testing in canines |
| US11406681B2 (en) | 2019-12-23 | 2022-08-09 | Hemopet | Compound for treating oxidative stress in mammals |
| US11596663B2 (en) | 2019-12-23 | 2023-03-07 | Hemopet | Compound for treating oxidative stress in canines |
| KR102332569B1 (ko) * | 2020-03-05 | 2022-01-04 | 서울대학교병원 | 심정지 후 예후에 관한 정보를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능한 기록 매체 |
| ES2922403B2 (es) * | 2021-03-03 | 2023-12-11 | Fundacion Para La Investigacion Biomedica Del Hospital Univ La Paz Fibhulp | Biomarcadores para el pronóstico de pacientes que han sufrido una hemorragia subaracnoidea aneurismática (SAH) |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447545A (en) | 1980-11-03 | 1984-05-08 | New England Deaconess Hospital | Bladder cancer detection |
| US5350842A (en) | 1986-09-30 | 1994-09-27 | Board Of Regents, The University Of Texas System | DNAs encoding Treponema pallidum antigens |
| US5114923A (en) | 1988-05-31 | 1992-05-19 | California Biotechnology Inc. | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| US5422393A (en) | 1988-07-11 | 1995-06-06 | Naturon Pharmaceutical Corporation | Natriuretic hormone |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| EP0461180A4 (en) | 1989-03-01 | 1992-05-06 | Cornell Research Foundation, Inc. | Development of a monoclonal antibody based detection system for listeria monocytogenes |
| DE69032598T2 (de) | 1989-06-23 | 1999-03-11 | Genentech, Inc., South San Francisco, Calif. | Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| CA2027434C (en) | 1990-10-12 | 1999-01-05 | George Jackowski | Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof |
| US5604105B1 (en) * | 1990-10-12 | 1999-08-24 | Spectral Diagnostics Inc | Method and device for diagnosingand distinguishing chest pain in early onset thereof |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| CA2107894C (en) | 1991-04-10 | 2003-10-14 | Kenneth F. Buechler | Crosstalk inhibitors and their uses |
| EP0579767B1 (de) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5482935A (en) | 1993-01-05 | 1996-01-09 | American Home Product Corporation | Anti-atherosclerotic use of 17 alpha-dihydroequilin |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6538121B1 (en) | 1994-11-01 | 2003-03-25 | Human Genome Sciences, Inc. | Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| MY129953A (en) * | 1996-02-09 | 2007-05-31 | Nippon Kayaku Kk | Epoxy resin, epoxy resin composition and hardened product thereof |
| DE69733560T2 (de) | 1996-03-04 | 2006-05-11 | Scios Inc., Fremont | TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP |
| US5645995A (en) | 1996-04-12 | 1997-07-08 | Baylor College Of Medicine | Methods for diagnosing an increased risk for breast or ovarian cancer |
| US5690103A (en) | 1996-06-20 | 1997-11-25 | Groth; Torgny Lars | Detection/exclusion of acute myocardial infarction using neural network analysis of measurements of biochemical markers |
| KR19990071477A (ko) | 1996-09-20 | 1999-09-27 | 아테로제닉스, 인코포레이티드 | 염증성질환의진단방법및매개체 |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| EP0869393B1 (de) | 1997-03-31 | 2000-05-31 | Fuji Photo Film Co., Ltd. | Positiv-arbeitende photoempfindliche Zusammensetzung |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| ES2256952T3 (es) | 1997-09-11 | 2006-07-16 | SHIONOGI & CO., LTD. | Inmunoanalisis para bnp. |
| WO1999018442A1 (en) * | 1997-10-07 | 1999-04-15 | Centocor, Inc. | Diagnosis of thrombotic events by detecting p-selectin |
| US6099469A (en) | 1998-06-02 | 2000-08-08 | Armstrong; E. Glenn | Reflex algorithm for early and cost effective diagnosis of myocardial infractions suitable for automated diagnostic platforms |
| US6117644A (en) | 1998-06-04 | 2000-09-12 | Ottawa Heart Institute Research Corporation | Predicting and detecting cardiac allograft rejection |
| US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
| AU761451B2 (en) | 1998-09-29 | 2003-06-05 | Vladimir Berezin | NCAM binding compounds |
| CA2263063C (en) | 1999-02-26 | 2004-08-10 | Skye Pharmatech Incorporated | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| AT407580B (de) | 1999-08-20 | 2001-04-25 | Biomedica Gmbh | Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay |
| US6268223B1 (en) | 1999-08-27 | 2001-07-31 | Viatech Imagin, Llc | Assay for detecting damage to the central nervous system |
| WO2001018801A1 (en) | 1999-09-02 | 2001-03-15 | Asahi Glass Company, Limited | Optical head |
| GB9929140D0 (en) | 1999-12-10 | 2000-02-02 | Univ Geneve | Diagnostic assay for stroke |
| US6443889B1 (en) | 2000-02-10 | 2002-09-03 | Torgny Groth | Provision of decision support for acute myocardial infarction |
| AU2001268233A1 (en) | 2000-06-08 | 2001-12-17 | Chiron Corporation | Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| AUPR005600A0 (en) * | 2000-09-12 | 2000-10-05 | University Of Sydney, The | Diagnostic assay |
| US6670138B2 (en) * | 2000-11-01 | 2003-12-30 | Agy Therapeutics, Inc. | Method of diagnosing ischemic stroke via UCP-2 detection |
| WO2002039114A2 (en) | 2000-11-13 | 2002-05-16 | Sigma-Aldrich Co. | Improved assay and reagents or immunological determination of analyte concentration |
| AU2002307100A1 (en) | 2001-04-06 | 2002-10-21 | Immunex Corporation | Use of tumor necrosis factor inhibitors to treat cardiovascular disease |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| EP1322957B1 (de) * | 2001-05-04 | 2009-08-12 | Biosite Incorporated | Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs |
| JP4357293B2 (ja) | 2001-06-27 | 2009-11-04 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 |
| ATE380175T1 (de) | 2001-06-27 | 2007-12-15 | Smithkline Beecham Corp | Pyrrolidine als dipeptidyl peptidase inhibitoren |
| US6627457B2 (en) * | 2001-07-30 | 2003-09-30 | Quest Diagnostics Investments Incorporated | Methods for detecting pregnancy |
| AUPS169202A0 (en) | 2002-04-11 | 2002-05-16 | Goetze, Jens Peter | Neuropeptide assay |
| US20050181386A1 (en) | 2003-09-23 | 2005-08-18 | Cornelius Diamond | Diagnostic markers of cardiovascular illness and methods of use thereof |
-
2002
- 2002-08-20 DE DE60233949T patent/DE60233949D1/de not_active Expired - Lifetime
- 2002-08-20 WO PCT/US2002/026604 patent/WO2003016910A1/en not_active Ceased
- 2002-08-20 US US10/225,082 patent/US7427490B2/en not_active Expired - Lifetime
- 2002-08-20 EP EP02757275A patent/EP1419388B1/de not_active Expired - Lifetime
- 2002-08-20 AT AT02757275T patent/ATE445160T1/de not_active IP Right Cessation
- 2002-08-20 CA CA002457775A patent/CA2457775A1/en not_active Abandoned
- 2002-08-20 JP JP2003521366A patent/JP2005522669A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005522669A (ja) | 2005-07-28 |
| DE60233949D1 (de) | 2009-11-19 |
| EP1419388B1 (de) | 2009-10-07 |
| EP1419388A1 (de) | 2004-05-19 |
| US20030119064A1 (en) | 2003-06-26 |
| WO2003016910A1 (en) | 2003-02-27 |
| CA2457775A1 (en) | 2003-02-27 |
| EP1419388A4 (de) | 2006-02-15 |
| US7427490B2 (en) | 2008-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE445160T1 (de) | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon | |
| WO2006036220A3 (en) | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof | |
| WO2002089657A3 (en) | Diagnostic markers of acute coronary syndromes and methods of use thereof | |
| US20160341742A1 (en) | Methods and materials for monitoring myeloma using quantitative mass spectrometry | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| BRPI0720035A2 (pt) | métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit | |
| EP1895302A3 (de) | Verfahren zum Nachweis von kolorektalem Krebs in menschlichen Proben | |
| DE69115926D1 (de) | Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen | |
| WO2007080597A3 (en) | Polynucleotide and polypeptide sequences and methods for diagnosis | |
| ATE401342T1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| BRPI0412110A (pt) | genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| JPWO2010004962A1 (ja) | 線維筋痛症の検査法 | |
| WO2006113210A3 (en) | Diagnostic multimarker serological profiling | |
| ATE314648T1 (de) | Diagnostisches verfahren für asthma | |
| EP1476757A4 (de) | Verfahren und kit zur krebsvorhersage | |
| WO2004040312A3 (fr) | Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie | |
| WO2007046811A3 (en) | Diagnostic markers of stroke and cerebral injury and methods of use thereof | |
| ATE557277T1 (de) | Verfahren zur diagnose von endometriose mittels tfpi-2 protein | |
| JP2009210469A (ja) | 血清たんぱく質の解析法 | |
| DE602005023329D1 (de) | VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8 | |
| WO2007071829A3 (en) | Methods and means related to diseases | |
| DE69610496D1 (de) | Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren | |
| DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |